IUHSA
CRSP icon

Itau Unibanco Holding S.A.’s CRISPR Therapeutics CRSP Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.7K Buy
+1,095
New +$57.7K ﹤0.01% 275
2026
Q1 		– Sell
-1,060
Closed -$55.6K – 375
2025
Q4 		$55.6K Buy
1,060
+168
+19% +$10.1K ﹤0.01% 244
2025
Q3 		$57.8K Hold
892
– – ﹤0.01% 232
2025
Q2 		$43.4K Sell
892
-12
-1% -$464 ﹤0.01% 271
2025
Q1 		$31K Sell
904
-12
-1% -$509 ﹤0.01% 325
2024
Q4 		$36.1K Buy
916
+157
+21% +$7.41K ﹤0.01% 308
2024
Q3 		$35.7K Buy
759
+113
+17% +$5.73K ﹤0.01% 209
2024
Q2 		$34.9K Buy
+646
New +$37.4K ﹤0.01% 192
2024
Q1 		– Sell
-1,498
Closed -$93.8K – 177
2023
Q4 		$93.8K Sell
1,498
-1,023
-41% -$56.6K ﹤0.01% 182
2023
Q3 		$114K Buy
2,521
+245
+11% +$12.7K 0.01% 186
2023
Q2 		$128K Buy
2,276
+675
+42% +$38.3K 0.01% 211
2023
Q1 		$72.4K Sell
1,601
-80
-5% -$3.88K ﹤0.01% 307
2022
Q4 		$67.8K Buy
1,681
+633
+60% +$33.6K ﹤0.01% 320
2022
Q3 		$68K Sell
1,048
-361
-26% -$26.2K ﹤0.01% 364
2022
Q2 		$86K Sell
1,409
-566
-29% -$33.3K ﹤0.01% 301
2022
Q1 		$124K Buy
1,975
+21
+1% +$1.32K ﹤0.01% 264
2021
Q4 		$154K Buy
1,954
+1,147
+142% +$100K ﹤0.01% 187
2021
Q3 		$90K Buy
807
+180
+29% +$22.6K ﹤0.01% 196
2021
Q2 		$102K Buy
+627
New +$76.3K 0.01% 139

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Itau Unibanco Holding S.A.'s CRSP Position: Q2 2026 in Review

Itau Unibanco Holding S.A. opened a new position in CRISPR Therapeutics (CRSP) in Q2 2026: 1,095 shares worth $59.7K. The stake represents ﹤0.01% of the portfolio and ranks #275 among its holdings. This is a return to the name: Itau Unibanco Holding S.A. previously reported a position in CRSP as recently as Q4 2025.

Itau Unibanco Holding S.A. first reported a position in CRSP in Q2 2021 and has held it in 19 quarters since. The position peaked at $154K in Q4 2021. 523 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Itau Unibanco Holding S.A. held 1,095 shares of CRISPR Therapeutics worth $59.7K as of Q2 2026.
  • CRISPR Therapeutics was a new Itau Unibanco Holding S.A. position in Q2 2026.
  • CRISPR Therapeutics made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q2 2026, its #275 holding.
  • Itau Unibanco Holding S.A. first reported a position in CRISPR Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • Itau Unibanco Holding S.A.'s CRISPR Therapeutics position peaked at $154K in Q4 2021.
  • 523 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.